Conservative treatment of lamivudine-induced rhabdomyolysis in a patient with acute exacerbation of chronic hepatitis B
-
- Hayashi Hidemi
- Department of Gastroenterology, Asahikawa Red Cross Hospital
-
- Sawada Koji
- Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahiakwa Medical University
-
- Hasebe Takumu
- Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahiakwa Medical University
-
- Nakajima Syunsuke
- Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahiakwa Medical University
-
- Abe Masami
- Department of Gastroenterology, Asahikawa Red Cross Hospital
-
- Hosoki Yayoi
- Department of Gastroenterology, Asahikawa Red Cross Hospital
-
- Ohtake Takaaki
- Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahiakwa Medical University Department of Clinical Gastroenterology and Hepatology on Co-operative Network, Asahikawa Medical University
-
- Fujii Tsuneshi
- Department of Gastroenterology, Asahikawa Red Cross Hospital
-
- Fujiya Mikihiro
- Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahiakwa Medical University
-
- Kohgo Yutaka
- Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahiakwa Medical University
-
- Hasebe Chitomi
- Department of Gastroenterology, Asahikawa Red Cross Hospital
Bibliographic Information
- Other Title
-
- 保存的治療にて救命し得たラミブジン誘発横紋筋融解症合併B型慢性肝炎急性増悪の1例
- 症例報告 保存的治療にて救命し得たラミブジン誘発横紋筋融解症合併B型慢性肝炎急性増悪の1例
- ショウレイ ホウコク ホゾンテキ チリョウ ニテ キュウメイ シエタ ラミブジン ユウハツ オウモンキン ユウカイショウ ガッペイ Bガタ マンセイ カンエン キュウセイ ゾウアク ノ 1レイ
Search this article
Description
A 50-year old man with chronic hepatitis B (CHB), dyslipidemia, nephrosclerosis, hypertension, and gout was referred to our hospital with a complaint of general fatigue. He was diagnosed with an acute exacerbation of CHB (AE of CHB) and treated with entecavir (ETV); however, his creatinine level increased. As ETV induced renal dysfunction or HBV associated nephropathy were suspected, ETV was discontinued and lamivudine (LAM) was administrated. After LAM treatment, aspartate aminotransferase (AST), serum creatinine kinase, and myoglobin levels markedly increased, and he was diagnosed with LAM-associated rhabdomyolysis. Immediate discontinuation of LAM and intravenous fluid therapy completely improved rhabdomyolysis. Although LAM-induced rhabdomyolysis is rare, rhabdomyolysis is poor prognosis with AE of CHB. When AST level unexpectedly increases despite of LAM administration in patients with AE of CHB, rhabdomyolysis should be considered as a differential diagnosis.
Journal
-
- Kanzo
-
Kanzo 56 (7), 341-347, 2015
The Japan Society of Hepatology
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679770442112
-
- NII Article ID
- 130005090877
-
- NII Book ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- NDL BIB ID
- 026614446
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed